We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
General description of the gene and the encoded protein(s) using information from HGNC and Ensembl, as well as predictions made by the Human Protein Atlas project.
Gene namei
Official gene symbol, which is typically a short form of the gene name, according to HGNC.
Cancer-related genes FDA approved drug targets Plasma proteins Transporters
Predicted locationi
All transcripts of all genes have been analyzed regarding the location(s) of corresponding protein based on prediction methods for signal peptides and transmembrane regions.
Genes with at least one transcript predicted to encode a secreted protein, according to prediction methods or to UniProt location data, have been further annotated and classified with the aim to determine if the corresponding protein(s) are secreted or actually retained in intracellular locations or membrane-attached.
Remaining genes, with no transcript predicted to encode a secreted protein, will be assigned the prediction-based location(s).
The annotated location overrules the predicted location, so that a gene encoding a predicted secreted protein that has been annotated as intracellular will have intracellular as the final location.
Gene information from Ensembl and Entrez, as well as links to available gene identifiers are displayed here. Information was retrieved from Ensembl if not indicated otherwise.
Chromosome
15
Cytoband
q22.2
Chromosome location (bp)
60347134 - 60402883
Number of transcriptsi
Number of protein-coding transcripts from the gene as defined by Ensembl.
The Structure section provides predicted structures from the Alphafold protein structure database and available experimental structures from Protein Data Bank (PDB).
In the Structure drop-down menu all experimental structures from PDB are available for selection and display. The structures are displayed using the NGL Viewer and can be zoomed-in and rotated either manually or by checking the Autorotate box. The Color scheme can be selected to show the residue index, chain name or confidence score (as B-factors and pLDDT score for experimental and predicted structures, respectively). The positions for available antigen sequences in the structure are shown if Antigens is turned to ON, and the Variants slider can be used to show the positions of clinical and population variants.https://github.com/nglviewer/ngl
The protein browser displays the antigen location on the target protein(s) and the features of the target protein. The tabs at the top of the protein view section can be used to switch between the different splice variants to which an antigen has been mapped.
At the top of the view, the position of the antigen (identified by the corresponding HPA identifier) is shown as a green bar. A yellow triangle on the bar indicates a <100% sequence identity to the protein target.
Below the antigens, the maximum percent sequence identity of the protein to all other proteins from other human genes is displayed, using a sliding window of 10 aa residues (HsID 10) or 50 aa residues (HsID 50). The region with the lowest possible identity is always selected for antigen design, with a maximum identity of 60% allowed for designing a single-target antigen (read more).
The curve in blue displays the predicted antigenicity i.e. the tendency for different regions of the protein to generate an immune response, with peak regions being predicted to be more antigenic.The curve shows average values based on a sliding window approach using an in-house propensity scale. (read more).
If a signal peptide is predicted by a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius (turquoise) and/or transmembrane regions (orange) are predicted by MDM, these are displayed.
Low complexity regions are shown in yellow and InterPro regions in green. Common (purple) and unique (grey) regions between different splice variants of the gene are also displayed (read more), and at the bottom of the protein view is the protein scale.
The protein information section displays alternative protein-coding transcripts (splice variants) encoded by this gene according to the Ensembl database.
The ENSP identifier links to the Ensembl website protein summary, while the ENST identifier links to the Ensembl website transcript summary for the selected splice variant. The data in the UniProt column can be expanded to show links to all matching UniProt identifiers for this protein.
The protein classes assigned to this protein are shown if expanding the data in the protein class column. Parent protein classes are in bold font and subclasses are listed under the parent class.
The Gene Ontology terms assigned to this protein are listed if expanding the Gene ontology column. The length of the protein (amino acid residues according to Ensembl), molecular mass (kDalton), predicted signal peptide (according to a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius) and the number of predicted transmembrane region(s) (according to MDM) are also reported.
Transporters Transporter channels and pores Predicted secreted proteins Predicted intracellular proteins Intracellular proteins predicted by MDM and MDSEC Plasma proteins Cancer-related genes Candidate cancer biomarkers FDA approved drug targets Small molecule drugs Mapped to neXtProt neXtProt - Evidence at protein level Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0001525 [angiogenesis] GO:0001765 [membrane raft assembly] GO:0001786 [phosphatidylserine binding] GO:0001921 [positive regulation of receptor recycling] GO:0002020 [protease binding] GO:0003723 [RNA binding] GO:0004859 [phospholipase inhibitor activity] GO:0004867 [serine-type endopeptidase inhibitor activity] GO:0005262 [calcium channel activity] GO:0005509 [calcium ion binding] GO:0005515 [protein binding] GO:0005544 [calcium-dependent phospholipid binding] GO:0005546 [phosphatidylinositol-4,5-bisphosphate binding] GO:0005576 [extracellular region] GO:0005604 [basement membrane] GO:0005615 [extracellular space] GO:0005634 [nucleus] GO:0005737 [cytoplasm] GO:0005765 [lysosomal membrane] GO:0005768 [endosome] GO:0005811 [lipid droplet] GO:0005886 [plasma membrane] GO:0005912 [adherens junction] GO:0006900 [vesicle budding from membrane] GO:0008092 [cytoskeletal protein binding] GO:0009986 [cell surface] GO:0010951 [negative regulation of endopeptidase activity] GO:0016020 [membrane] GO:0016032 [viral process] GO:0016323 [basolateral plasma membrane] GO:0019834 [phospholipase A2 inhibitor activity] GO:0030496 [midbody] GO:0031267 [small GTPase binding] GO:0031340 [positive regulation of vesicle fusion] GO:0031902 [late endosome membrane] GO:0031982 [vesicle] GO:0032804 [negative regulation of low-density lipoprotein particle receptor catabolic process] GO:0035578 [azurophil granule lumen] GO:0035722 [interleukin-12-mediated signaling pathway] GO:0036035 [osteoclast development] GO:0042470 [melanosome] GO:0042802 [identical protein binding] GO:0043086 [negative regulation of catalytic activity] GO:0043312 [neutrophil degranulation] GO:0044090 [positive regulation of vacuole organization] GO:0044147 [negative regulation of development of symbiont involved in interaction with host] GO:0044548 [S100 protein binding] GO:0045121 [membrane raft] GO:0046790 [virion binding] GO:0048306 [calcium-dependent protein binding] GO:0052362 [catabolism by host of symbiont protein] GO:0052405 [negative regulation by host of symbiont molecular function] GO:0062023 [collagen-containing extracellular matrix] GO:0070062 [extracellular exosome] GO:0070588 [calcium ion transmembrane transport] GO:0098609 [cell-cell adhesion] GO:0098641 [cadherin binding involved in cell-cell adhesion] GO:1905581 [positive regulation of low-density lipoprotein particle clearance] GO:1905597 [positive regulation of low-density lipoprotein particle receptor binding] GO:1905599 [positive regulation of low-density lipoprotein receptor activity] GO:1905602 [positive regulation of receptor-mediated endocytosis involved in cholesterol transport] GO:1990665 [AnxA2-p11 complex] GO:1990667 [PCSK9-AnxA2 complex]
Transporters Transporter channels and pores Predicted secreted proteins Predicted intracellular proteins Intracellular proteins predicted by MDM and MDSEC Plasma proteins Cancer-related genes Candidate cancer biomarkers FDA approved drug targets Small molecule drugs Mapped to neXtProt neXtProt - Evidence at protein level Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0001525 [angiogenesis] GO:0001765 [membrane raft assembly] GO:0001786 [phosphatidylserine binding] GO:0001921 [positive regulation of receptor recycling] GO:0002020 [protease binding] GO:0003723 [RNA binding] GO:0004859 [phospholipase inhibitor activity] GO:0004867 [serine-type endopeptidase inhibitor activity] GO:0005262 [calcium channel activity] GO:0005509 [calcium ion binding] GO:0005515 [protein binding] GO:0005544 [calcium-dependent phospholipid binding] GO:0005546 [phosphatidylinositol-4,5-bisphosphate binding] GO:0005576 [extracellular region] GO:0005604 [basement membrane] GO:0005615 [extracellular space] GO:0005634 [nucleus] GO:0005737 [cytoplasm] GO:0005765 [lysosomal membrane] GO:0005768 [endosome] GO:0005811 [lipid droplet] GO:0005886 [plasma membrane] GO:0005912 [adherens junction] GO:0006900 [vesicle budding from membrane] GO:0008092 [cytoskeletal protein binding] GO:0009986 [cell surface] GO:0010951 [negative regulation of endopeptidase activity] GO:0016020 [membrane] GO:0016032 [viral process] GO:0016323 [basolateral plasma membrane] GO:0019834 [phospholipase A2 inhibitor activity] GO:0030496 [midbody] GO:0031267 [small GTPase binding] GO:0031340 [positive regulation of vesicle fusion] GO:0031902 [late endosome membrane] GO:0031982 [vesicle] GO:0032804 [negative regulation of low-density lipoprotein particle receptor catabolic process] GO:0035578 [azurophil granule lumen] GO:0035722 [interleukin-12-mediated signaling pathway] GO:0036035 [osteoclast development] GO:0042470 [melanosome] GO:0042802 [identical protein binding] GO:0043086 [negative regulation of catalytic activity] GO:0043312 [neutrophil degranulation] GO:0044090 [positive regulation of vacuole organization] GO:0044147 [negative regulation of development of symbiont involved in interaction with host] GO:0044548 [S100 protein binding] GO:0045121 [membrane raft] GO:0046790 [virion binding] GO:0048306 [calcium-dependent protein binding] GO:0052362 [catabolism by host of symbiont protein] GO:0052405 [negative regulation by host of symbiont molecular function] GO:0062023 [collagen-containing extracellular matrix] GO:0070062 [extracellular exosome] GO:0070588 [calcium ion transmembrane transport] GO:0098609 [cell-cell adhesion] GO:0098641 [cadherin binding involved in cell-cell adhesion] GO:1905581 [positive regulation of low-density lipoprotein particle clearance] GO:1905597 [positive regulation of low-density lipoprotein particle receptor binding] GO:1905599 [positive regulation of low-density lipoprotein receptor activity] GO:1905602 [positive regulation of receptor-mediated endocytosis involved in cholesterol transport] GO:1990665 [AnxA2-p11 complex] GO:1990667 [PCSK9-AnxA2 complex]
Transporters Transporter channels and pores Predicted secreted proteins Predicted intracellular proteins Intracellular proteins predicted by MDM and MDSEC Plasma proteins Cancer-related genes Candidate cancer biomarkers FDA approved drug targets Small molecule drugs Mapped to neXtProt neXtProt - Evidence at protein level Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0001525 [angiogenesis] GO:0001765 [membrane raft assembly] GO:0001786 [phosphatidylserine binding] GO:0001921 [positive regulation of receptor recycling] GO:0002020 [protease binding] GO:0003723 [RNA binding] GO:0004859 [phospholipase inhibitor activity] GO:0004867 [serine-type endopeptidase inhibitor activity] GO:0005262 [calcium channel activity] GO:0005509 [calcium ion binding] GO:0005515 [protein binding] GO:0005544 [calcium-dependent phospholipid binding] GO:0005546 [phosphatidylinositol-4,5-bisphosphate binding] GO:0005576 [extracellular region] GO:0005604 [basement membrane] GO:0005615 [extracellular space] GO:0005634 [nucleus] GO:0005737 [cytoplasm] GO:0005765 [lysosomal membrane] GO:0005768 [endosome] GO:0005811 [lipid droplet] GO:0005886 [plasma membrane] GO:0005912 [adherens junction] GO:0006900 [vesicle budding from membrane] GO:0008092 [cytoskeletal protein binding] GO:0009986 [cell surface] GO:0010951 [negative regulation of endopeptidase activity] GO:0016020 [membrane] GO:0016032 [viral process] GO:0016323 [basolateral plasma membrane] GO:0019834 [phospholipase A2 inhibitor activity] GO:0030496 [midbody] GO:0031267 [small GTPase binding] GO:0031340 [positive regulation of vesicle fusion] GO:0031902 [late endosome membrane] GO:0031982 [vesicle] GO:0032804 [negative regulation of low-density lipoprotein particle receptor catabolic process] GO:0035578 [azurophil granule lumen] GO:0035722 [interleukin-12-mediated signaling pathway] GO:0036035 [osteoclast development] GO:0042470 [melanosome] GO:0042802 [identical protein binding] GO:0043086 [negative regulation of catalytic activity] GO:0043312 [neutrophil degranulation] GO:0044090 [positive regulation of vacuole organization] GO:0044147 [negative regulation of development of symbiont involved in interaction with host] GO:0044548 [S100 protein binding] GO:0045121 [membrane raft] GO:0046790 [virion binding] GO:0048306 [calcium-dependent protein binding] GO:0052362 [catabolism by host of symbiont protein] GO:0052405 [negative regulation by host of symbiont molecular function] GO:0062023 [collagen-containing extracellular matrix] GO:0070062 [extracellular exosome] GO:0070588 [calcium ion transmembrane transport] GO:0098609 [cell-cell adhesion] GO:0098641 [cadherin binding involved in cell-cell adhesion] GO:1905581 [positive regulation of low-density lipoprotein particle clearance] GO:1905597 [positive regulation of low-density lipoprotein particle receptor binding] GO:1905599 [positive regulation of low-density lipoprotein receptor activity] GO:1905602 [positive regulation of receptor-mediated endocytosis involved in cholesterol transport] GO:1990665 [AnxA2-p11 complex] GO:1990667 [PCSK9-AnxA2 complex]
Transporters Transporter channels and pores Predicted secreted proteins Predicted intracellular proteins Intracellular proteins predicted by MDM and MDSEC Plasma proteins Cancer-related genes Candidate cancer biomarkers FDA approved drug targets Small molecule drugs Mapped to neXtProt neXtProt - Evidence at protein level Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0001525 [angiogenesis] GO:0001765 [membrane raft assembly] GO:0001786 [phosphatidylserine binding] GO:0001921 [positive regulation of receptor recycling] GO:0002020 [protease binding] GO:0003723 [RNA binding] GO:0004859 [phospholipase inhibitor activity] GO:0004867 [serine-type endopeptidase inhibitor activity] GO:0005262 [calcium channel activity] GO:0005509 [calcium ion binding] GO:0005515 [protein binding] GO:0005544 [calcium-dependent phospholipid binding] GO:0005546 [phosphatidylinositol-4,5-bisphosphate binding] GO:0005576 [extracellular region] GO:0005604 [basement membrane] GO:0005615 [extracellular space] GO:0005634 [nucleus] GO:0005737 [cytoplasm] GO:0005765 [lysosomal membrane] GO:0005768 [endosome] GO:0005811 [lipid droplet] GO:0005886 [plasma membrane] GO:0005912 [adherens junction] GO:0006900 [vesicle budding from membrane] GO:0008092 [cytoskeletal protein binding] GO:0009986 [cell surface] GO:0010951 [negative regulation of endopeptidase activity] GO:0016020 [membrane] GO:0016032 [viral process] GO:0016323 [basolateral plasma membrane] GO:0019834 [phospholipase A2 inhibitor activity] GO:0030496 [midbody] GO:0031267 [small GTPase binding] GO:0031340 [positive regulation of vesicle fusion] GO:0031902 [late endosome membrane] GO:0031982 [vesicle] GO:0032804 [negative regulation of low-density lipoprotein particle receptor catabolic process] GO:0035578 [azurophil granule lumen] GO:0035722 [interleukin-12-mediated signaling pathway] GO:0036035 [osteoclast development] GO:0042470 [melanosome] GO:0042802 [identical protein binding] GO:0043086 [negative regulation of catalytic activity] GO:0043312 [neutrophil degranulation] GO:0044090 [positive regulation of vacuole organization] GO:0044147 [negative regulation of development of symbiont involved in interaction with host] GO:0044548 [S100 protein binding] GO:0045121 [membrane raft] GO:0046790 [virion binding] GO:0048306 [calcium-dependent protein binding] GO:0052362 [catabolism by host of symbiont protein] GO:0052405 [negative regulation by host of symbiont molecular function] GO:0062023 [collagen-containing extracellular matrix] GO:0070062 [extracellular exosome] GO:0070588 [calcium ion transmembrane transport] GO:0098609 [cell-cell adhesion] GO:0098641 [cadherin binding involved in cell-cell adhesion] GO:1905581 [positive regulation of low-density lipoprotein particle clearance] GO:1905597 [positive regulation of low-density lipoprotein particle receptor binding] GO:1905599 [positive regulation of low-density lipoprotein receptor activity] GO:1905602 [positive regulation of receptor-mediated endocytosis involved in cholesterol transport] GO:1990665 [AnxA2-p11 complex] GO:1990667 [PCSK9-AnxA2 complex]
The Human Protein Atlas project is funded
